Description

Laferon-FarmBiotek Lyophilisate for Solution for Injections 3 mln IU №10 Vial

Ingredients:

Each vial contains 3 million international units of Interferon alfa-2b.

Dosage:

The dosage of Laferon-FarmBiotek lyophilisate should be determined by a healthcare professional based on the individual’s condition. It is typically administered via subcutaneous or intramuscular injection.

Indications:

Laferon-FarmBiotek is indicated for the treatment of certain viral infections, including hepatitis B and C, as well as certain types of cancer such as melanoma and leukemia.

Contraindications:

Do not use Laferon-FarmBiotek if you are allergic to Interferon alfa-2b or any other components of the product. It is also contraindicated in patients with autoimmune disorders.

Directions:

Follow the instructions provided by your healthcare provider for the proper administration of Laferon-FarmBiotek. It is important to adhere to the recommended dosage and schedule.

Scientific Evidence:

Studies have shown that Interferon alfa-2b, the active ingredient in Laferon-FarmBiotek, exhibits antiviral, antiproliferative, and immunomodulatory effects. These properties make it effective in combating viral infections and certain types of cancer.

Research published in the Journal of Viral Hepatitis demonstrated the efficacy of Interferon alfa-2b in the treatment of chronic hepatitis C, with high rates of sustained virological response observed in patients.

Additional Information:

Laferon-FarmBiotek lyophilisate for solution for injections is a potent medication that should only be used under the supervision of a healthcare professional. It is important to discuss any existing medical conditions or medications with your doctor before starting treatment with Laferon-FarmBiotek.

Patients may experience flu-like symptoms, fatigue, and injection site reactions as common side effects of Laferon-FarmBiotek therapy. Regular monitoring and follow-up appointments are essential to ensure the safety and efficacy of treatment.